Screener
CNS Pharmaceuticals CNSP Q3 2024 earnings
Reported November 14, 2024 · Before market open
EPS-$150.06Miss by $149.96
EPS estimate-$0.10
Next report
Nov 18, 2026 (in 2 months)EPS estimate-$0.27
Versus estimates
Diluted EPS
FAQ
- When did CNS Pharmaceuticals report Q3 2024 earnings?
- CNS Pharmaceuticals (CNSP) reported Q3 2024 earnings on November 14, 2024 before market open.
- What were CNS Pharmaceuticals's Q3 2024 revenue and EPS?
- CNS Pharmaceuticals reported eps of $-150.06 for Q3 2024.
- Did CNS Pharmaceuticals beat estimates in Q3 2024?
- EPS missed the consensus estimate of $-0.10 by $149.96.
- Where can I find CNS Pharmaceuticals's Q3 2024 SEC filings?
- You can read the 10-Q periodic report (0001683168-24-008125) directly on SEC EDGAR. The filing index links above go to sec.gov.
